Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Selecta Biosciences Inc. (SELB)

1.675   -0.805 (-32.46%) 10-01 14:54
Open: 1.56 Pre. Close: 2.48
High: 1.82 Low: 1.48
Volume: 12,211,761 Market Cap: 179M
Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company is headquartered in Watertown, Massachusetts and currently employs 39 full-time employees. The firm using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are designed to modulate the immune system to treat rare and serious diseases. The firm is engaged in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its product candidates are in various stages of clinical and preclinical development. Its SVP technology encapsulates an immunomodulator in biodegradable nanoparticles to induce antigen-specific immune tolerance to mitigate the formation of anti-drug antibodies (ADAs) in response to life-sustaining biologic drugs. The firm's lead product candidate, SEL-212, is a combination of a therapeutic enzyme and its SVP technology designed to be the biologic treatment for gout.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.601 - 2.615 2.615 - 2.625
Low: 2.41 - 2.424 2.424 - 2.434
Close: 2.459 - 2.481 2.481 - 2.499

Technical analysis

as of: 2020-10-01 2:39:16 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.64     One year: 3.20
Support: Support1: 1.48    Support2: 1.23
Resistance: Resistance1: 2.26    Resistance2: 2.74
Pivot: 2.46
Moving Average: MA(5): 2.32     MA(20): 2.42
MA(100): 2.83     MA(250): 2.60
MACD: MACD(12,26): -0.07     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 39.39     %D(3): 50.66
RSI: RSI(14): 26.30
52-week: High: 4.83  Low: 1.28  Change(%): -5.6
Average Vol(K): 3-Month: 131786  10-Days: 234020

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SELB has closed below the lower band by 36.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 7.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 01 Oct 2020
Selecta Biosciences Inc. (SELB) Reveals an Earnings Mystery - The News Heater

Thu, 01 Oct 2020
Shares Of Selecta Biosciences, Inc. (SELB) Recently Pulled Back, Is It Ready To Climb? - Invest Million

Wed, 30 Sep 2020
Sobi and Selecta Biosciences announce topline data of SEL-212 from the phase 2 COMPARE study supporting the potential for important clinical improvement in patients with Chronic Refractory Gout - Yahoo Finance

Wed, 30 Sep 2020
Selecta Biosciences and Sobi Announce Topline Data of SEL-212 from the Phase 2 COMPARE Trial Supporting the Potential for Important Clinical Improvement in Patients with Chronic Refractory Gout - Benzinga

Thu, 24 Sep 2020
Selecta Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire

Thu, 24 Sep 2020
Analysts Mean recommendation for Selecta Biosciences Inc. (SELB) was 1.70: Is this the key time? - The InvestChronicle

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 107
Shares Float (M) 73
% Held by Insiders 17.36
% Held by Institutions 60.21
Shares Short (K) 8,800
Shares Short P. Month (K) 9,380

Stock Financials

EPS -0.972
EPS Est This Year -3.170
EPS Est Next Year -2.690
Book Value (p.s.) -0.130
Profit Margin
Operating Margin -895.00
Return on Assets (ttm) -60.9
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) -0.191
Sales Per Share 0.062
EBITDA (p.s.) -0.549
Qtrly Earnings Growth
Operating Cash Flow (M) -48
Levered Free Cash Flow (M) -26

Stock Valuations

PE Ratio -1.73
PEG Ratio
Price to Book value -12.92
Price to Sales 27.07
Price to Cash Flow -3.79

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.